AU556112B2 - Pharmaceutical compositions of buspirone - Google Patents

Pharmaceutical compositions of buspirone

Info

Publication number
AU556112B2
AU556112B2 AU22793/83A AU2279383A AU556112B2 AU 556112 B2 AU556112 B2 AU 556112B2 AU 22793/83 A AU22793/83 A AU 22793/83A AU 2279383 A AU2279383 A AU 2279383A AU 556112 B2 AU556112 B2 AU 556112B2
Authority
AU
Australia
Prior art keywords
buspirone
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU22793/83A
Other languages
English (en)
Other versions
AU2279383A (en
Inventor
Lloyd E. Allen
Leslie A. Riblet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of AU2279383A publication Critical patent/AU2279383A/en
Application granted granted Critical
Publication of AU556112B2 publication Critical patent/AU556112B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU22793/83A 1982-12-23 1983-12-22 Pharmaceutical compositions of buspirone Expired AU556112B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US452686 1982-12-23
US06/452,686 US4438119A (en) 1982-12-23 1982-12-23 Method for alleviation of extrapyramidal motor disorders

Publications (2)

Publication Number Publication Date
AU2279383A AU2279383A (en) 1984-06-28
AU556112B2 true AU556112B2 (en) 1986-10-23

Family

ID=23797489

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22793/83A Expired AU556112B2 (en) 1982-12-23 1983-12-22 Pharmaceutical compositions of buspirone

Country Status (7)

Country Link
US (1) US4438119A (enExample)
JP (1) JPS59130215A (enExample)
AU (1) AU556112B2 (enExample)
BE (1) BE898540A (enExample)
DE (1) DE3346237A1 (enExample)
PH (1) PH18968A (enExample)
ZA (1) ZA839451B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU592121B2 (en) * 1985-10-25 1990-01-04 Bristol-Myers Squibb Company Method for alleviation of panic disorders

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4640921A (en) * 1986-02-04 1987-02-03 Bristol-Myers Treatment of sexual dysfunction with buspirone
US4687772A (en) * 1986-10-07 1987-08-18 Bristol-Myers Company Method for improvement of short term memory
US4777173A (en) * 1987-03-25 1988-10-11 Bristol-Myers Company Method for treatment of alcohol abuse
DE3736974A1 (de) * 1987-10-31 1989-05-11 Troponwerke Gmbh & Co Kg Verwendung von 2-pyrimidinyl-1-piperazin-derivaten
US5468749A (en) * 1988-08-30 1995-11-21 Gawin; Frank H. Method for treatment of substance addiction
US6432956B1 (en) 1990-02-12 2002-08-13 William C. Dement Method for treatment of sleep apneas
US5633009A (en) * 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones
US5824680A (en) * 1991-08-31 1998-10-20 Bayer Aktiengesellschaft Ipsapirone for the treatment of alzheimer's disease by improving memory
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
UA73981C2 (en) * 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
US7053092B2 (en) 2001-01-29 2006-05-30 Otsuka Pharmaceutical Co., Ltd. 5-HT1a receptor subtype agonist
EP1408964B1 (en) * 2001-07-26 2007-01-24 MERCK PATENT GmbH Use of 2- 5-(4-fluorophenyl)-3-pyridylmethylaminomethyl|-chromane and its physiologically acceptable salts
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
GT200600414A (es) * 2005-09-12 2007-09-20 Sal de glucuranato de compuesto de piperazine
GT200600416A (es) * 2005-09-12 2007-09-20 Sales salicilato y gentisato de un compuesto de piperazina
PE20070523A1 (es) * 2005-09-12 2007-06-28 Wyeth Corp Formulacion de liberacion sostenida del glucuronato de (8-{4-[3-(5-fluoro-1h-indol-3-il)-propil]-piperazin-1-il}-2-metil-4h-benzo[1,4]oxazin-3-ona
HRP20161402T1 (hr) * 2010-10-15 2016-12-30 Contera Pharma Aps Kombinacije agonista serotoninskih receptora za liječenje poremećaja kretanja
ES2654787T3 (es) 2012-04-18 2018-02-15 Contera Pharma Aps Formulación farmacéutica disponible por vía oral adecuada para la gestión mejorada de trastornos del movimiento
HUE039750T2 (hu) * 2014-06-26 2019-02-28 Contera Pharma Aps Hidroxi-buspiron mozgászavarok kezelésére
WO2018011181A1 (en) 2016-07-11 2018-01-18 Contera Pharma Aps Pulsatile drug delivery system for treating morning akinesia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU592121B2 (en) * 1985-10-25 1990-01-04 Bristol-Myers Squibb Company Method for alleviation of panic disorders

Also Published As

Publication number Publication date
PH18968A (en) 1985-11-26
US4438119A (en) 1984-03-20
BE898540A (fr) 1984-06-22
ZA839451B (en) 1984-09-26
JPH0422889B2 (enExample) 1992-04-20
DE3346237A1 (de) 1984-07-05
JPS59130215A (ja) 1984-07-26
AU2279383A (en) 1984-06-28

Similar Documents

Publication Publication Date Title
AU556112B2 (en) Pharmaceutical compositions of buspirone
AU3503984A (en) Pharmaceutical compositions
AU2199283A (en) Pharmaceutical compositions of m-chloro-alpha-t- butylaminopropiophenone
GB2159055B (en) Pharmaceutical compositions of 3,7,11,15-tetra-methylhexadec-1-en-3-ol
AU553013B2 (en) Shampoo compositions
AU567329B2 (en) Pharmaceutical composition of rifampicin
GB2117766B (en) Pharmaceutical compositions
AU572102B2 (en) Composition of hydrochloric acid
AU557513B2 (en) Pharmaceutical compositions of spiro-germanium compounds
AU576739B2 (en) 2-piperazinyl-or-homo-piperazinyl-quinazoline derivatives and pharmaceutical compositions
AU2116583A (en) Pharmaceutical compositions of 2-piperazinopyrimidine derivatives
AU1459183A (en) Anti-ulcer pharmaceutical composition
AU562822B2 (en) Pharmaceutical composition of clotrimazole
AU558670B2 (en) Pharmaceutical compositions
DE3377696D1 (en) Pharmaceutical compositions
AU561447B2 (en) Pharmaceutical composition of cyproheptadine
GB2114001B (en) Nasel pharmaceutical compositions
AU554039B2 (en) Pharmaceutical compositions of detoxidied endotoxin
AU2081583A (en) Oral compositions
AU556749B2 (en) Pharmaceutical compositions of 2-fluoroestradiol
AU565613B2 (en) Nasal pharmaceutical composition
AU1956083A (en) Compositions containing benzoxadiazole - or benzthiadiazole - dihydropyridines
AU551840B2 (en) Pharmaceutical compositions containing an extract of mandassi
AU563456B2 (en) Pharmaceutical composition of tolnaftate
AU533574B1 (en) Preparation of fluorobenzophenones

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired